174 related articles for article (PubMed ID: 18158768)
21. Arsenic trioxide up-regulates Fas expression in human osteosarcoma cells.
Yang GF; Li XH; Zhao Z; Wang WB
Chin Med J (Engl); 2010 Jul; 123(13):1768-73. PubMed ID: 20819644
[TBL] [Abstract][Full Text] [Related]
22. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
23. Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma.
Liu P; Sun L; Zhou DS; Zhang P; Wang YH; Li D; Li QH; Feng RJ
Sci Rep; 2015 Dec; 5():17387. PubMed ID: 26619950
[TBL] [Abstract][Full Text] [Related]
24. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
25. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
26. [Effects of arsenic trioxide on the autoimmunity and survival time in BXSB lupus mice].
Xia XR; Lin SX; Zhou Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Feb; 27(2):138-41. PubMed ID: 17345664
[TBL] [Abstract][Full Text] [Related]
27. Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis.
Yeh KY; Chang JW; Li YY; Wang CH; Wang HM
Head Neck; 2011 May; 33(5):734-42. PubMed ID: 20737493
[TBL] [Abstract][Full Text] [Related]
28. Antitumor effect of arsenic trioxide in murine xenograft model.
Kito M; Matsumoto K; Wada N; Sera K; Futatsugawa S; Naoe T; Nozawa Y; Akao Y
Cancer Sci; 2003 Nov; 94(11):1010-4. PubMed ID: 14611680
[TBL] [Abstract][Full Text] [Related]
29. Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):493-8. PubMed ID: 16563655
[TBL] [Abstract][Full Text] [Related]
30. Arsenic trioxide induces autophagic cell death in osteosarcoma cells via the ROS-TFEB signaling pathway.
Wu B; Tan M; Cai W; Wang B; He P; Zhang X
Biochem Biophys Res Commun; 2018 Jan; 496(1):167-175. PubMed ID: 29307831
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinoma.
Lam SK; Mak JC; Zheng CY; Li YY; Kwong YL; Ho JC
Int J Oncol; 2014 Jun; 44(6):2093-102. PubMed ID: 24691991
[TBL] [Abstract][Full Text] [Related]
32. Preparation, characterization, in vivo and in vitro studies of arsenic trioxide Mg-Fe ferrite magnetic nanoparticles.
Yang GF; Li XH; Zhao Z; Wang WB
Acta Pharmacol Sin; 2009 Dec; 30(12):1688-93. PubMed ID: 19960013
[TBL] [Abstract][Full Text] [Related]
33. Intravenous administration of arsenic trioxide encapsulated in liposomes inhibits the growth of C6 gliomas in rat brains.
Zhao S; Zhang X; Zhang J; Zhang J; Zou H; Liu Y; Dong X; Sun X
J Chemother; 2008 Apr; 20(2):253-62. PubMed ID: 18467254
[TBL] [Abstract][Full Text] [Related]
34. Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid.
Campbell RA; Sanchez E; Steinberg JA; Baritaki S; Gordon M; Wang C; Shalitin D; Chen H; Pang S; Bonavida B; Said J; Berenson JR
Br J Haematol; 2007 Aug; 138(4):467-78. PubMed ID: 17587338
[TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
[TBL] [Abstract][Full Text] [Related]
36. Delivery of Arsenic Trioxide by Multifunction Nanoparticles To Improve the Treatment of Hepatocellular Carcinoma.
Wu Q; Chen X; Wang P; Wu Q; Qi X; Han X; Chen L; Meng X; Xu K
ACS Appl Mater Interfaces; 2020 Feb; 12(7):8016-8029. PubMed ID: 31997633
[TBL] [Abstract][Full Text] [Related]
37. 3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation.
Sethi P; Jyoti A; Swindell EP; Chan R; Langner UW; Feddock JM; Nagarajan R; O'Halloran TV; Upreti M
Nanomedicine; 2015 Nov; 11(8):2013-23. PubMed ID: 26282381
[TBL] [Abstract][Full Text] [Related]
38. Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor.
Monzen H; Griffin RJ; Williams BW; Amano M; Ando S; Hasegawa T
Radiat Med; 2004; 22(4):205-11. PubMed ID: 15468939
[TBL] [Abstract][Full Text] [Related]
39. [Targeted distribution of cis-platin magnetic nanoparticles in mice].
Zhang HZ; Xie MQ; Kang Z; Shen H; Wang L
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1756-9. PubMed ID: 18971164
[TBL] [Abstract][Full Text] [Related]
40. Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells.
Lee PC; Kakadiya R; Su TL; Lee TC
Neoplasia; 2010 May; 12(5):376-87. PubMed ID: 20454509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
